Company Name | Jenner Vaccine Foundation |
---|---|
Company Status | Active |
Company Number | 03079818 |
Incorporation Date | 14 July 1995 (28 years, 9 months ago) |
Dissolution Date | — |
Category | Pri/Lbg/Nsc (Private, Limited By Guarantee, No Share Capital, Use Of 'Limited' Exemption) |
Previous Name | The Edward Jenner Institute For Vaccine Research |
Current Directors | 8 |
Business Industry | Professional, Scientific and Technical Activities |
---|---|
Business Activity | Research and Experimental Development On Social Sciences and Humanities |
Latest Accounts | 31 March 2023 (1 year, 1 month ago) |
Next Accounts Due | 31 December 2024 (8 months from now) |
Accounts Category | Full |
Accounts Year End | 31 March |
Latest Return | 30 June 2023 (10 months ago) |
Next Return Due | 14 July 2024 (2 months, 2 weeks from now) |
Registered Address | C/O Jenner Institute Old Road Campus Research Building Roosevelt Drive Oxford OX3 7DQ |
---|---|
Shared Address | This company doesn't share its address with any other companies |
Constituency | Oxford East |
---|---|
Region | South East |
County | Oxfordshire |
Built Up Area | Oxford |
Accounts Year End | 31 March |
---|---|
Category | Full |
Latest Accounts | 31 March 2023 (1 year, 1 month ago) |
Next Accounts Due | 31 December 2024 (8 months from now) |
Latest Return | 30 June 2023 (10 months ago) |
---|---|
Next Return Due | 14 July 2024 (2 months, 2 weeks from now) |
SIC Industry | Professional, scientific and technical activities |
---|---|
SIC 2003 (7320) | R & D on soc sciences & humanities |
SIC 2007 (72200) | Research and experimental development on social sciences and humanities |
25 July 2023 | Appointment of Dr Jan Theunis Poolman as a director on 17 July 2023 |
---|---|
11 July 2023 | Confirmation statement made on 30 June 2023 with no updates |
13 May 2023 | Full accounts made up to 31 March 2022 |
15 July 2022 | Notification of The Pirbright Institute as a person with significant control on 30 June 2016 |
14 July 2022 | Withdrawal of a person with significant control statement on 14 July 2022 |